LAMP1 and type 2 diabetes mellitus: In addition, the proportion of S-reactive CD4+T cells with cytotoxic potential (GZMB+CD107a+) was also comparable between participants with type 2 diabetes and HCs (Figures 2B, 3A; Supplementary Figures 5A, 6A).